The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of intensification of induction II chemotherapy and liberalization of stem cell donor source on outcome for children with high risk acute myeloid leukemia: A report from the Children’s Oncology Group.
 
Richard Aplenc
Honoraria - Sigma-Tau
Expert Testimony - Wiggin and Dana
Travel, Accommodations, Expenses - Sigma-Tau
 
Lillian Sung
No Relationships to Disclose
 
Jessica Anne Pollard
No Relationships to Disclose
 
Lisa Brodersen
Employment - Hematologics
Stock and Other Ownership Interests - Hematologics
 
Michael Loken
Employment - Hematologics
Leadership - Hematologics
Stock and Other Ownership Interests - Hematologics
 
Robert B Gerbing
Stock and Other Ownership Interests - Pfizer
 
Kelly D. Getz
No Relationships to Disclose
 
Soheil Meshinchi
No Relationships to Disclose
 
William G. Woods
No Relationships to Disclose
 
E. Anders Kolb
No Relationships to Disclose
 
Todd Allen Alonzo
No Relationships to Disclose
 
Alan S. Gamis
Consulting or Advisory Role - Novartis